Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (26)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  3. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

2022

  1. Ten steps to eliminating hepatitis C in hospitals

    Nature Reviews Gastroenterology and Hepatology

2020

  1. The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300

2018

  1. Impact of human-Associated Escherichia coli clonal groups in Antarctic pinnipeds: Presence of ST73, ST95, ST141 and ST131

    Scientific Reports, Vol. 8, Núm. 1

2015

  1. Biofilm formation and quorum-sensing-molecule production by clinical isolates of Serratia liquefaciens

    Applied and Environmental Microbiology, Vol. 81, Núm. 10, pp. 3306-3315

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  2. Clinical impact of HTLV-1 infection in Spain: Implications for public health and mandatory screening [3]

    Journal of Acquired Immune Deficiency Syndromes

  3. Monoclonal antibodies raised in Btkxid mice reveal new antigenic relationships and molecular interactions among gp53 and other Trichinella glycoproteins

    Molecular and Biochemical Parasitology, Vol. 125, Núm. 1-2, pp. 173-183

1998

  1. Genetic analysis of human immunodeficiency virus type 2 strains from spain

    AIDS Research and Human Retroviruses

1996

  1. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388

1995

  1. HIV‐2 in Native Spanish Individuals

    Vox Sanguinis

  2. HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)

    Medicina clínica, Vol. 105, Núm. 7, pp. 246-250

  3. HTLV‐I‐Associated Illnesses in Spain

    Vox Sanguinis